medicareIRAinflation reduction actConsultingHEORMarket Access White Paper 15 November 2024 Inflation Reduction Act (IRA): Assessing the implications of Medicare drug price negotiations for drug development sponsors Download PDF Share Share Share on Facebook Share on Linkedin Share on Twitter Share on Threads Share via Email Copy link to clipboard